Cabaletta Bio, Inc. — Director's Dealing 2020

Mar 4, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cabaletta Bio, Inc. (CABA)
CIK: 0001759138
Period of Report: 2020-03-01

Reporting Person: Chang David J. (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-01	Stock Option (Right to Buy)	$14.94	A	38238	Acquired	2030-02-28	Common Stock (38238)	Direct

Footnotes

F1: This option vests over four years, with 25% vesting on March 1, 2021 and the remaining shares vesting in 12 equal quarterly installments thereafter.